InvestorsHub Logo
Followers 181
Posts 13912
Boards Moderated 1
Alias Born 11/02/2009

Re: None

Thursday, 03/11/2010 1:00:35 AM

Thursday, March 11, 2010 1:00:35 AM

Post# of 212277
"Our corporate counsel has notified us that due to the valuation of the recent acquisition of the BioHarp Business, in a restricted stock transaction, XTend Medical is now required to take the necessary action to become a fully-reporting company. Due to the requirements based on the Securities and Exchange Act of 1934, XTend is now required to file a Form 10 with the SEC and move to the OTCBB or higher exchange.

I'm still thinking this part is required and must be completed by a certain time-frame ... one of the reasons I didn't sell today. With an up-listing comes a very nice gap and from what I've observed from other up-listings a 30-60% surge. imo